Reporting owner · CIK 0001940272

ADAR1 Capital Management, LLC

Visual SEC Form 4 history across 1 companies, 6 transactions and 2 filings.

10%TENAX THERAPEUTICS, INC.
Open-market mix
Filings2Form 4 records
Buying$3.2M6 purchases
Selling$00 sales
Net value$3.2MBuys minus sells
Companies11 securities
Most recentSep 02, 2026buy

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Average return+10.0%Across 6 open-market buys
Median return+10.0%Half the buys outperformed this
How it's computed

For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.

  • Window follows the rest of the summary (all-history or last 3 months).
  • Only buys with a resolved price context are counted.
  • Includes both positive and negative outcomes; gains and losses net out at the per-buy level.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-54Aug 262Sep 26

Net value flow

Buys minus sells

Aug 26
$2.5M
Sep 26
$659.2K

Transaction texture

Ownership and ticket size

Average P/S size$532.6K
Median P/S size$348.6K
Direct0
Indirect6
Sep 02, 2026buy

Filing-only signals

Deterministic matches in this insider's history

Latest Form 4 facts

Quick context from source filings

Latest transaction

buy at TENAX THERAPEUTICS, INC. on Sep 02, 2026 valued at $337,586.

Review SEC filing
Latest buy

buy at TENAX THERAPEUTICS, INC. on Sep 02, 2026 valued at $337,586.

Review SEC filing
Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

ADAR1 Capital Management, LLC Insider Activity FAQ

SEC Form 4 context

Who is ADAR1 Capital Management, LLC?

ADAR1 Capital Management, LLC is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001940272.

Which companies has ADAR1 Capital Management, LLC reported transactions for?

TENAX THERAPEUTICS, INC.

When was ADAR1 Capital Management, LLC's latest insider buy?

buy at TENAX THERAPEUTICS, INC. on Sep 02, 2026 valued at $337,586.

When was ADAR1 Capital Management, LLC's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.